Publications | Lund University Publications

1 – 9 of 9

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Lofvenberg%2C+E%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Lofvenberg%2C+E%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2013
Mark Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study
Holte, H. ; Leppa, S. ; Bjorkholm, M. ; Fluge, O. ; Jyrkkio, S. ; Delabie, J. ; Sundstrom, C. ; Karjalainen-Lindsberg, M. -L. ; Erlanson, M. and Kolstad, A. , et al. (2013) In Annals of Oncology 24(5). p.1385-1392
- Contribution to journal › Article
2008
Mark Long Term Efficacy And Tolerability Of Anagrelide In Myeloproliferative Disorders
Ejerblad, M. E. ; Andreasson, B. ; Bjorkholm, M. ; Lofvenberg, E. ; Markevarn, B. ; Nilsson, Lars ^LU ; Palmblad, J. ; Samuelsson, J. and Birgegard, G. (2008) 13th Congress of the European-Hematology-Association In Haematologica-The Hematology Journal 93. p.0746-0746
- Contribution to journal › Published meeting abstract
2005
Mark Management of patients with polycythaemia vera: results of a survey among Swedish haematologists
Andreasson, B ; Lofvenberg, E and Westin, Jan ^LU (2005) In European Journal of Haematology 74(6). p.489-495
- Contribution to journal › Article
Mark Intensive treatment and stem cell transplantation in chronic myelogenous leukemia: Long-term follow-up
Simonsson, B ; Oberg, G ; Bjoreman, M ; Bjorkholm, M ; Carneskog, J ; Karlsson, K ; Gahrton, G ; Grimfors, G ; Hast, R and Karle, H , et al. (2005) In Acta Haematologica 113(3). p.155-162
- Contribution to journal › Article
2004
Mark Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders
Birgegard, G ; Bjorkholm, M ; Kutti, J ; Larfars, G ; Lofvenberg, E ; Markevarn, B ; Merup, M ; Palmblad, J ; Mauritzson, Nils and Westin, Jan ^LU , et al. (2004) In Haematologica 89(5). p.520-527
- Contribution to journal › Article
Mark Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival
Olsson-Stromberg, U ; Simonsson, B ; Ahlgren, T ; Bjorkholm, M ; Carlsson, K ; Gahrton, G ; Hast, R ; Lofvenberg, E ; Linder, O and Ljungman, P , et al. (2004) In The Hematology Journal 5(6). p.462-466
- Contribution to journal › Article
2003
Mark Mutated V-H genes and preferential V(H)3-21 use define new subsets of mantle cell lymphoma
Walsh, SH ; Thorselius, M ; Johnson, Anna ^LU ; Soderberg, O ; Jerkernan, M ; Bjorck, E ; Eriksson, I ; Thunberg, U ; Landgren, O and Ehinger, Mats ^LU , et al. (2003) In Blood 101(10). p.4047-4054
- Contribution to journal › Article
Mark A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin plus granulocyte colony-stimulating factor: significant effects on quality of life
Hellstrom-Lindberg, E ; Gulbrandsen, N ; Lindberg, G ; Ahlgren, T ; Dahl, IMS ; Dybedal, I ; Grimfors, G ; Hesse-Sundin, E ; Hjorth, M and Kanter-Lewensohn, L , et al. (2003) In British Journal of Haematology 120(6). p.1037-1046
- Contribution to journal › Article
2002
Mark Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase - a report from the Swedish CML Group
Turesson, Ingemar ^LU ; Axdorph, U ; Vilen, L ; Stenke, L ; Uden, AM ; Grimfors, G ; Bjorkholm, M ; Carneskog, J ; Hansen, J and Linder, O , et al. (2002) In British Journal of Haematology 118(4). p.1048-1054
- Contribution to journal › Article

your query:: Remove author: Lofvenberg, E